Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

Clinical trial NCT00851643 · COMPLETED

Trial details

NCT number: NCT00851643
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Human Papilloma Virus Cervical Cancer Vulvar Cancer Vaginal Cancer Genital Warts

Start date: 2006-04-01
Primary completion: 2007-12-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.